Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-06-30 View official record Methodology

Covered recipient · General Payments record

MANORAMA MATHUR

Allopathic & Osteopathic Physicians Pediatrics

NPI
1245212570
CMS profile
146979
Location
MALDEN, MA

General Payments · PY2019–2025

$1,659.56

  • Reported across 79 records
  • CMS publication 2026-06-30

Latest program year · PY2025

$332.50

13 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2025 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $332.50 13

By paying entity

PY2025 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $157.96 6
GlaxoSmithKline, LLC. $46.86 2
BAXTER HEALTHCARE $44.76 1
Agios Pharmaceuticals, Inc. $24.60 1
PFIZER INC. $22.22 1
Seqirus USA Inc $19.64 1
Exact Sciences Corporation $16.46 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $329.78 16
PY2020 $241.62 12
PY2021 $259.78 13
PY2022 $173.03 9
PY2023 $72.17 3
PY2024 $250.68 13
PY2025 $332.50 13

Payment records · PY2025 (13)

Sorted by paying entity, then date · as published by CMS

Program year 2025 201920202021202220232024 Record-level detail is published for PY2025; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Agios Pharmaceuticals, Inc. $24.60 03/11/2025 Food and Beverage Undisputed 06/30/2026 1253251489 CMS
AstraZeneca Pharmaceuticals LP $27.29 02/28/2025 Food and Beverage Undisputed 06/30/2026 1207053660 CMS
AstraZeneca Pharmaceuticals LP $29.09 04/04/2025 Food and Beverage Undisputed 06/30/2026 1206805891 CMS
AstraZeneca Pharmaceuticals LP $26.88 07/21/2025 Food and Beverage Undisputed 06/30/2026 1206197660 CMS
AstraZeneca Pharmaceuticals LP $24.43 09/25/2025 Food and Beverage Undisputed 06/30/2026 1206815512 CMS
AstraZeneca Pharmaceuticals LP $22.67 10/17/2025 Food and Beverage Undisputed 06/30/2026 1206669906 CMS
AstraZeneca Pharmaceuticals LP $27.60 11/15/2025 Food and Beverage Undisputed 06/30/2026 1207089923 CMS
Baxter Healthcare $44.76 07/23/2025 Food and Beverage Undisputed 06/30/2026 1181551588 CMS
Exact Sciences Corporation $16.46 06/02/2025 Food and Beverage Undisputed 06/30/2026 1235689562 CMS
GlaxoSmithKline, LLC. $23.93 05/15/2025 Food and Beverage Undisputed 06/30/2026 1190540182 CMS
GlaxoSmithKline, LLC. $22.93 08/20/2025 Food and Beverage Undisputed 06/30/2026 1190669038 CMS
PFIZER INC. $22.22 05/23/2025 Food and Beverage Undisputed 06/30/2026 1229893008 CMS
Seqirus USA Inc $19.64 07/24/2025 Food and Beverage Undisputed 06/30/2026 1201099300 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.